Breast Cancer Clinical Trial 2018-068

[LCID Study Number: 2018-068]

S1703: Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored With Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients With Metastatic Hormone Receptor Positive Breast Cancer

The purpose of this study is to find out if a different approach to monitoring metastatic breast cancer is as good as the usual approach.

Disease/Condition: Breast Cancer

Department: Hematology and Oncology

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody; Winchester Hospital

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421

View NCT ID 03723928 on ClinicalTrials.gov
Protocol #: 2018-068
Principal Investigator(s): Corrine Zarwan
Study Coordinator(s): Carol Bovest
Trial Phase: Sponsor Initiated Study Observational